Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-24-001012
Filing Date
2024-11-15
Accepted
2024-11-15 21:17:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3021
  Complete submission text file 0001968582-24-001012.txt   4962
Mailing Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086
Business Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Subject) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: 144 | Act: 33 | File No.: 001-39587 | Film No.: 241469586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SEQUOIA CAPITAL 2800 SAND HILL ROAD, SUITE 101 MENLO PARK CA 94025
Business Address SEQUOIA CAPITAL 2800 SAND HILL ROAD, SUITE 101 MENLO PARK CA 94025 650-854-3927
Sequoia Grove UK, L.P. (Reporting) CIK: 0001863644 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 144